Roger Markwald to Hyaluronan Receptors
This is a "connection" page, showing publications Roger Markwald has written about Hyaluronan Receptors.
Connection Strength
0.899
-
FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells. Int J Mol Sci. 2021 Jan 13; 22(2).
Score: 0.167
-
Transforming growth factor ?1 (TGF?1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis. J Biol Chem. 2017 06 23; 292(25):10490-10519.
Score: 0.129
-
Transforming growth factor ?1 (TGF?1) regulates CD44V6 expression and activity through extracellular signal-regulated kinase (ERK)-induced EGR1 in pulmonary fibrogenic fibroblasts. J Biol Chem. 2017 06 23; 292(25):10465-10489.
Score: 0.129
-
Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-?1 signaling in interstitial lung disease. J Biol Chem. 2014 Mar 14; 289(11):7856-72.
Score: 0.102
-
Hyaluronan-CD44 interactions as potential targets for cancer therapy. FEBS J. 2011 May; 278(9):1429-43.
Score: 0.085
-
Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor. J Biol Chem. 2010 Jun 25; 285(26):19821-32.
Score: 0.079
-
Delivery of CD44 shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ MICE. J Biol Chem. 2009 May 01; 284(18):12432-46.
Score: 0.073
-
Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer. Connect Tissue Res. 2008; 49(3):219-24.
Score: 0.068
-
Tissue-specific shRNA delivery: a novel approach for gene therapy in cancer. Connect Tissue Res. 2008; 49(3):265-9.
Score: 0.068